[Preliminary evaluation of a histocytological association predicted in a single sample of uterine exploration via a modified pipette: Mark II pipette].
The pipelle has become the sampling tool of choice for histological detection of endometrial adenocarcinoma. Some practitioners still prefer cytological sampling. The distal extremity of the pipelle has been modified to allow removal of both types of samples simultaneously. The aim of this preliminary study was to evaluate the feasibility of this method. A positive agreement between histological and cytological results was found in 10 out of the 12 cases examined, among which an adenocarcinoma was positively detected. A prospective study on larger size must confirm these first findings. The new modified pipelle (Pipelle Mark II) offers a possible approach for reduction of false negatives.
Clinique de la Muette, Paris.
E
E
Cornier
M
M
Jondet
A
A
Janaud
R
R
Chakroun
D000230:Adenocarcinoma / Q000175:diagnosis / Q000473:pathology; D001706:Biopsy / Q000295:instrumentation*; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D011446:Prospective Studies; D013048:Specimen Handling / Q000295:instrumentation*; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014599:Uterus / Q000473:pathology*
Evaluation préliminaire d'une association histo-cytologique prélevée en un seul geste pour exploration endo-utérine par une pipelle modifiée: la pipelle Mark II.